Skip to main content
Retrovirology logoLink to Retrovirology
editorial
. 2008 Nov 25;5:106. doi: 10.1186/1742-4690-5-106

H-index, mentoring-index, highly-cited and highly-accessed: how to evaluate scientists?

Kuan-Teh Jeang 1,
PMCID: PMC2607307  PMID: 19032780

Abstract

How best to evaluate scientists within a peer group is a difficult task. This editorial discusses the use of the H-index and total citations. It also raises the consideration of a mentoring-index and the value of understanding the frequency that a published paper is accessed by readers.

Editorial

Key performance indicators

A challenging question in peer-reviewed science is how to distribute judiciously resources amongst a large number of competing researchers. What are the "key performance indicators" that should be used to evaluate scientists who pursue similar research interests? One popular discussion is to ask how many times a person has published articles in journals with a high impact factor (IF). Several "quirks" in the way that a journal's IF is calculated have prompted many individuals to question whether this number reliably reflects the citation frequency of research articles that are published in the journal [1]. Recently, a scientist's H-index (HI) [2] has been suggested as a more informative measure of his/her scientific productivity [1].

H-index and total citations

The predictive value of the HI does have limitations [3]. However, in a 2007 survey of Retrovirology editorial board members, it was noted that an individual's H-number correlated well with the absolute frequency that his/her published papers were cited in the scientific literature [1]. A mid-October 2008 update of the 2007 survey, using numbers from the Scopus database http://www.scopus.com, continues to support this correlation (Table 1). Thus, within a well-delimited field of research, a scientist's HI and his/her total citations appear to be reasonably quantitative peer-measures, seemingly superior to the colloquial banters about "high impact" papers. It should be noted that different databases measure HI numbers over varying time periods, and are not directly comparable. In general, a HI number increases with the length of time over which it is measured; hence, older scientists would usually be expected to sport HI numbers higher than their younger counterparts

Table 1.

H-index and citation frequencies of selected Retrovirology editorial board members.

Title Name Role within Retrovirology Institution City Country H index Total times cited since 1996
Dr. Kuan-Teh Jeang Editor-in-Chief NIH Bethesda USA 43 9082

Dr. Monsef Benkirane Editor CNRS Montpellier France 20 1751

Dr. Ben Berkhout Editor Academic Med. Ctr Amsterdam the Netherlands 38 6022

Dr. Andrew ML Lever Editor Cambridge University Cambridge UK 19 1919

Dr. Mark Wainberg Editor McGill University Montreal Canada 39 9519

Dr. Masahiro Fujii Editor Niigata University Niigata Japan 19 1686

Dr. Michael Lairmore Editor Ohio State University Columbus USA 20 1933

Dr. Michael Bukrinsky Ed Board George Washington Univ Washington DC USA 25 4913

Dr. Dong-yan Jin Ed Board Hong Kong U Hong Kong China 22 2402

Dr. Klaus Strebel Ed Board NIH Bethesda USA 25 3889

Dr. Tom J. Hope Ed Board U. Illinois Chicago USA 26 4307

Dr. Ariberto Fassati Ed Board University College London England 11 524

Dr. Stephane Emiliani Ed Board Cochin Institute Paris France 17 1774

Dr. Patrick Green Ed Board Ohio State Columbus USA 17 918

Dr. Mauro Giacca Ed Board Int. Ctr. Genetics Trieste Italy 35 5051

Dr. Olivier Schwartz Ed Board Institut Pasteur Paris France 27 3657

Dr. Leonid Margolis Ed Board National Inst Child Health Bethesda USA 22 1745

Dr. Fatah Kashanchi Ed Board George Washington U. Washington DC USA 26 2503

Dr. Masao Matsuoka Ed Board Kyoto University Kyoto Japan 24 1992

Dr. Naoki Mori Ed Board University of the Ryukyus Okinawa Japan 24 1982

Dr. Chou-Zen Giam Ed Board Uniform Services Med School Bethesda USA 14 1454

Dr. David Derse Ed Board NCI Frederick USA 13 1667

Dr. Tatsuo Shioda Ed Board Osaka Univ Osaka Japan 24 1956

Dr. John Semmes Ed Board Eastern Virginia Med College Norfolk USA 27 2953

Dr. Anne Gatignol Ed Board McGill Univ. Montreal Canada 14 1012

Dr. Rogier Sanders Ed Board Academic Med Ctr. Amsterdam the Netherlands 13 845

Dr. Chen Liang Ed Board McGill Univ. Montreal Canada 19 915

Dr. Finn Skou Pedersen Ed Board University of Aarhus Aarhus Denmark 19 1490

Dr. Janice Clements Ed Board Johns Hopkins Med School Baltimore USA 23 3454

Dr. Renaud Mahieux Ed Board Pasteur Inst Paris France 23 1312

Dr. Chris Aiken Ed Board Vanderbilt University Nashville USA 18 2347

Dr. Neil Almond Ed Board NIBSC Potters Bar UK 12 1121

Dr. Stephen P. Goff Ed Board Columbia University New York USA 41 13771

Dr. Johnson Mak Ed Board Burnet Inst. Med. Research Victoria Australia 15 1298

Dr. Christine Kozak Ed Board NIH Bethesda USA 29 7489

Dr. Greg Towers Ed Board University College London UK 17 1392

Dr. Graham Taylor Ed Board Imperial College London UK 15 1567

Dr. Eric Cohen Ed Board Univ. Montreal Montreal Canada 27 3221

Dr. William Hall Ed Board University College Dublin Dublin Ireland 21 2071

Dr. Warner Greene Ed Board UCSF San Francisco USA 39 10133

Dr. Jean-luc Darlix Ed Board U. Lyon Lyon France 32 5654

Dr. Axel Rethwilm Ed Board U. Wuerzburg Wuerzburg Germany 22 2040

Dr. Eric Freed Ed Board NCI Frederick USA 29 4415

Dr. Toshiki Watanabe Ed Board Univ. of Tokyo Tokyo Japan 22 2167

Dr. Mari Kannagi Ed Board Tokyo Med and Dental U Tokyo Japan 15 1350

Dr. Frank Kirchhoff Ed Board University of Ulm Ulm Germany 30 4520

Dr. Jennifer Nyborg Ed Board Colorado State U Fort Collins USA 17 1571

Dr. Akifumi Takaori-Kondo Ed Board Kyoto University Kyoto Japan 13 589

Dr. Marc Sitbon Ed Board CNRS Montpellier France 12 690

Dr. Paul Gorry Ed Board MacFarlane Burnet Institute Melbourne Australia 13 607

Dr. David Harrich Ed Board Queensland Inst Medical Res. Brisbane Australia 12 1000

Dr. Susan Marriott Ed Board Baylor Houston USA 14 1021

Dr. Damian Purcell Ed Board U Melbourne Melbourne Australia 12 902

Dr. Alan Cochrane Ed Board U Toronto Toronto Canada 10 1080

Dr. Yiming Shao Ed Board China CDC Beijing China 13 977

Dr. Vinayaka Prasad Ed Board Albert Einstein College Medicine New York USA 18 1187

A time for a mentoring-index?

Scientists do research and also mentor younger colleagues. Good mentoring should be a significant consideration of one's contribution to science. The HI might measure research productivity, but currently there does not appear to be a "mentoring index" (MI). Accepting that mentoring is an important component of a scientist's career, one could propose to construct a MI derived as a composite value based on the current HI of trainees during an earlier period with a given mentor. For example, a MI for scientist X reflecting his/her mentoring influence during the 1991 to 1995 period could be calculated from the sum of today's HI for all the first authors from his/her laboratory on papers published during 1991 to 1995 with scientist X as the last author. As an example, for Kuan-Teh Jeang (KTJ) during the 1991–1995 period, there were eight different first authors who listed the same laboratory affiliation as KTJ and who published papers with KTJ as the last author. The eight individuals, (with current HI in parentheses) A. Gatignol (14), B. Berkhout (38), B. Dropulic (9). O.J. Semmes (27), Y.N. Chang (5), F. Majone (5), A. Joshi (2) and L.M. Huang (19), provide a total HI of 14 + 38 + 9 + 27 + 5 + 5 + 2 + 19 = 119. If one divides 119 by 8, a MI of 14.8 for KTJ is derived. This number could be used for comparing KTJ to others for mentoring contributions during a defined period (e.g. 1991 to 1995). Of course, comparisons are meaningful only when done amongst appropriate peer groups. A focus on using the HI of previous trainees in evaluating established scientists could encourage the development of long-lasting mentoring relationships that continue even after the trainees have departed the mentors' laboratories.

Frequency of citation versus frequency of access

The above discussions of HI, MI, citation frequencies, and impact factor presume the primacy of citations as a measure of scientific value. What if this presumption is off-the-mark? Is there another value that could be considered? In other areas of communication (book publishing, music distribution) where citation metrics are irrelevant, the numbers of readers (copies of books sold) and listeners (number of albums sold or songs downloaded) are used to gauge impact. In the modern internet era, the frequency of "hits" or accesses to portals such as YouTube or Facebook quantitatively gauges relative importance. In this respect, should the frequency of accesses to online Open Access scientific articles similarly matter? To begin to explore this question, I examined the top 15 "all time" most highly accessed papers at Retrovirology http://www.retrovirology.com/mostviewedalltime. In this dataset, four 2006 papers (excluding a meeting report, [4]) were identified that have been accessed 23,634; 8,592; 8,304; and 7,902 times respectively [5], [6], [7], [8]. These four highly accessed papers have been cited to date 14, 13, 15, and 14 times, placing them in the top 15% of cited Retrovirology papers published in 2006. On the other hand, the four Retrovirology papers published during 2006 that are currently the most frequently cited [9], [10], [11], [12] (cited 27, 23, 21, 20 times) are not the four which are the most highly accessed. Thus, high readership does seem to produce high citation frequency, but high citation frequency does not always require high readership. This pattern suggests that Open Access readers encompass those who simply read and those who read and also write papers that cite other papers. Citation numbers measure the latter group, while access numbers measure both groups. Arguably, it is unclear that a published paper's influence on one group (citations) counts while the less well-tabulated impact on the second group (accesses) counts not. The relative merits of citations versus accesses require further validation.

Acknowledgements

I thank Mark Wainberg, Andrew Lever, and Ben Berkhout for critical readings of this editorial. The values shown in Table 1 are to be viewed as illustrative examples and are not to be regarded as fully accurate. The views expressed are the author's personal opinion and do not represent the position of the author's employer, the National Institutes of Health, USA. Research in KTJ's laboratory is supported by NIAID Intramural funds. I thank Christina Bezon for assistance with Table 1.

Competing interests

The author declares that he has no competing interests.

Acknowledgments

Authors' contributions

KTJ wrote this editorial.

References

  1. Jeang KT. Impact factor, H index, peer comparisons, and Retrovirology: is it time to individualize citation metrics? Retrovirology. 2007;4:42. doi: 10.1186/1742-4690-4-42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hirsch JE. Does the H index have predictive power? Proc Natl Acad Sci USA. 2007;104:19193–19198. doi: 10.1073/pnas.0707962104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Honekopp J, Kleber J. Sometimes the impact factor outshines the H index. Retrovirology. 2008;5:88. doi: 10.1186/1742-4690-5-88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Freed EO, Mouland AJ. The cell biology of HIV-1 and other retroviruses. Retrovirology. 2006;3:77. doi: 10.1186/1742-4690-3-77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Scaria V, Hariharan M, Maiti S, Pillai B, Brahmachari SK. Host-virus interaction: a new role for microRNAs. Retrovirology. 2006;3 doi: 10.1186/1742-4690-3-68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Weiss RA. The discovery of endogenous retroviruses. Retrovirology. 2006;3:67. doi: 10.1186/1742-4690-3-67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ghafouri M, Amini S, Khalili K, Sawaya BE. HIV-1 associated dementia: symptoms and causes. Retrovirology. 2006;3:28. doi: 10.1186/1742-4690-3-28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Saumet A, Lecellier CH. Anti-viral RNA silencing: do we look like plants? Retrovirology. 2006;3:3. doi: 10.1186/1742-4690-3-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cavanagh MH, Landry S, Audet B, Arpin-André C, Hivin P, Paré ME, Thête J, Wattel E, Marriott SJ, Mesnard JM, Barbeau B. HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated. Retrovirology. 2006;3:15. doi: 10.1186/1742-4690-3-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cochrane AW, McNally MT, Mouland AJ. The retrovirus RNA trafficking granule: from birth to maturity. Retrovirology. 2006;3:18. doi: 10.1186/1742-4690-3-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model. Retrovirology. 2006;3:76. doi: 10.1186/1742-4690-3-76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Marcello A. Latency: the hidden HIV-1 challenge. Retrovirology. 2006;3:7. doi: 10.1186/1742-4690-3-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Retrovirology are provided here courtesy of BMC

RESOURCES